MicroTransponder Receives $7,000,000 Series B Funding Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    2802 Flintrock Trace Austin, TX 78738
  • Company Description
    MicroTransponder Inc. is a medical device development company with a strong neuroscience research focus. Our core technology is based on a previous technology developed in the DARPA Revolutionizing Prosthetics program by Dr. Larry Cauller at the University of Texas at Dallas. We have adapted this technology to create a wireless neurostimulator for the treatment of chronic pain and other neurological indications. Other products in the development pipeline include preclinical studies for the relief of tinnitus, motor and speech deficit after TBI and anxiety. We have raised more than $10M in private investment and grants, including 8 NIH grants.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series B
  • Proceeds Purposes
    This funding has allowed the Company to hire premier clinical and regulatory expertise and to prepare a series of clinical trials and regulatory filings on their initial product, the SAINT™ System for chronic pain.
  • M&A Terms
  • Venture Investor

Trending on Xconomy